MCID: URT004
MIFTS: 42

Urethral Syndrome

Categories: Nephrological diseases

Aliases & Classifications for Urethral Syndrome

Summaries for Urethral Syndrome

MedlinePlus : 44 The urethra is the tube that allows urine to pass out of the body. In men, it's a long tube that runs through the penis. It also carries semen in men. In women, it's short and is just above the vagina. Urethral problems may happen due to aging, illness, or injury. They include Urethral cancer - a rare cancer that happens more often in men Urethral stricture - a narrowing of the opening of the urethra Urethritis - inflammation of the urethra, sometimes caused by infection Urethral problems may cause pain or difficulty passing urine. You may also have bleeding or discharge from the urethra. Doctors diagnose urethral problems using different tests. These include urine tests, x-rays and an examination of the urethra with a scope called a cystoscope. Treatment depends on the cause of the problem. It may include medicines and, in severe cases, surgery.

MalaCards based summary : Urethral Syndrome, also known as urethral disease, is related to urethritis and acute cystitis, and has symptoms including pain in urethra An important gene associated with Urethral Syndrome is MRAP (Melanocortin 2 Receptor Accessory Protein). The drugs Lymecycline and Doxycycline have been mentioned in the context of this disorder. Affiliated tissues include testes, prostate and kidney.

Disease Ontology : 12 A urinary system disease that is located in the urethra.

Wikipedia : 77 Urethral syndrome is characterised by a set of symptoms typically associated with lower urinary tract... more...

Related Diseases for Urethral Syndrome

Diseases related to Urethral Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 35)
# Related Disease Score Top Affiliating Genes
1 urethritis 31.4 EXTL3 MRAP MT-TG PHB2
2 acute cystitis 29.9 BCKDHA KLK3
3 pyuria 10.3 BCKDHA MRAP
4 balanitis 10.3 MRAP PHB2
5 juvenile ankylosing spondylitis 10.3 MRAP PHB2
6 optic papillitis 10.3 EXTL3 MRAP
7 iritis 10.3 MRAP PHB2
8 enthesopathy 10.3 MRAP PHB2
9 bursitis 10.3 MRAP PHB2
10 ochronosis 10.3 HPD MRAP
11 tendinitis 10.3 MRAP PHB2
12 cervicitis 10.2 MRAP MT-TG
13 chorioretinitis 10.2 EXTL3 MRAP
14 urethral gland abscess 10.2
15 trichomoniasis 10.2 EXTL3 WASF3
16 bone inflammation disease 10.2 BCKDHA MRAP PHB2
17 transient arthritis 10.2 MRAP PHB2
18 urethral stricture 10.2 KLK3 MYZAP
19 cystitis 10.1
20 urethral diverticulum 10.1 KIDINS220 KLK3
21 interstitial cystitis 10.1
22 tabes dorsalis 10.0 EXTL3 KANTR
23 chlamydia 10.0
24 radiation cystitis 9.9 KANTR KLK3
25 prostatitis 9.9
26 fallopian tube disease 9.9 EXTL3 MT-TG MTRR WASF3
27 bacteriuria 9.8
28 tertiary neurosyphilis 9.7 EXTL3 KANTR
29 hypospadias 9.7
30 pyelonephritis 9.7
31 conjunctivitis 9.7
32 ophthalmia neonatorum 9.7
33 fibromyalgia 9.7
34 anus disease 9.6 EXTL3 KANTR KIDINS220 MT-TG MTRR
35 rectal disease 9.4 EXTL3 KANTR KIDINS220 KLK3 MT-TG MTRR

Comorbidity relations with Urethral Syndrome via Phenotypic Disease Network (PDN):


Acute Cystitis

Graphical network of the top 20 diseases related to Urethral Syndrome:



Diseases related to Urethral Syndrome

Symptoms & Phenotypes for Urethral Syndrome

UMLS symptoms related to Urethral Syndrome:


pain in urethra

Drugs & Therapeutics for Urethral Syndrome

Drugs for Urethral Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 171)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lymecycline Approved, Investigational Phase 4 992-21-2 5280963
2
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 564-25-0 54671203
3
Azithromycin Approved Phase 4,Phase 3,Phase 2 83905-01-5 55185 447043
4
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
5
Doxazosin Approved Phase 4 74191-85-8 3157
6
Alfuzosin Approved, Investigational Phase 4 81403-80-7 2092
7
Fesoterodine Approved Phase 4 286930-02-7, 286930-03-8 6918558
8
Tamsulosin Approved, Investigational Phase 4,Phase 2 106133-20-4 129211
9
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
10
Bupivacaine Approved, Investigational Phase 4,Phase 3 2180-92-9, 38396-39-3 2474
11
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
12
Acetaminophen Approved Phase 4 103-90-2 1983
13
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
14
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
15
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
16
Ibuprofen Approved Phase 4 15687-27-1 3672
17 Anti-Bacterial Agents Phase 4,Phase 3,Phase 1,Phase 2
18 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
19 Antimalarials Phase 4,Phase 3,Phase 2
20 Antiparasitic Agents Phase 4,Phase 3,Phase 2
21 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 1,Phase 2
22 Antiprotozoal Agents Phase 4,Phase 3,Phase 2
23 Analgesics Phase 4,Phase 1,Phase 2
24 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 1,Phase 2
25 Anesthetics Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
26 Analgesics, Non-Narcotic Phase 4,Phase 1,Phase 2
27 Antihypertensive Agents Phase 4
28 Adrenergic alpha-Antagonists Phase 4,Phase 2
29 Adrenergic Agents Phase 4,Phase 2
30 Muscarinic Antagonists Phase 4,Phase 2
31 Neurotransmitter Agents Phase 4,Phase 2
32 Cholinergic Agents Phase 4,Phase 2
33 Cholinergic Antagonists Phase 4,Phase 2
34 Adrenergic alpha-1 Receptor Antagonists Phase 4,Phase 2
35 Adrenergic Antagonists Phase 4,Phase 2
36 Tolterodine tartrate Phase 4 124937-52-6
37 Antirheumatic Agents Phase 4,Phase 3,Phase 2
38 Anti-Anxiety Agents Phase 4
39 Anticonvulsants Phase 4
40 Excitatory Amino Acids Phase 4
41 Tranquilizing Agents Phase 4
42 Antimanic Agents Phase 4
43 Central Nervous System Depressants Phase 4,Phase 3,Phase 2
44 Excitatory Amino Acid Antagonists Phase 4
45 Psychotropic Drugs Phase 4
46 Anesthetics, Local Phase 4,Phase 3,Phase 2
47 Autonomic Agents Phase 4
48 BB 1101 Phase 4
49 Cyclooxygenase Inhibitors Phase 4
50 Hormones Phase 4

Interventional clinical trials:

(show top 50) (show all 124)
# Name Status NCT ID Phase Drugs
1 Efficiency of Cold vs. Laser Internal Urethrotomy Treatment of Urethral Strictures Unknown status NCT01196572 Phase 4
2 Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced Unknown status NCT01661985 Phase 4 Azithromycin;Doxycycline;lymecycline
3 Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1 Completed NCT01661621 Phase 4 Detrusitol 4 mg QD;Doxazosin 4 mg QD
4 The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH Patients Completed NCT00696761 Phase 4 alfuzosin;alfuzosin;alfuzosin;alfuzosin
5 An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia Completed NCT00605319 Phase 4 Toviaz (Fesoterodine)
6 Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction Completed NCT00147654 Phase 4 Tolterodine ER 4 mg QD;Tamsulosin 0.4 mg QD
7 Gabapentin on Postoperative Pain Associated With Ureteroscopy and Stents Insertion Recruiting NCT03151746 Phase 4 Placebo;Gabapentin
8 Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty Not yet recruiting NCT03859024 Phase 4 Oxycodone;Acetaminophen;Gabapentin;celebrex;Bupivacaine;Ibuprofen 800 mg;Dexamethasone
9 Diagnosis of Urethral Stricture With Sono-urethrography vs Conventional Urethrography (SONO-URETHRA) Unknown status NCT01790776 Phase 3
10 Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA) Completed NCT00358462 Phase 3 Azithromycin;Doxycycline
11 Memokath® 044TW Stent for Treatment of Urethral Stricture Completed NCT00270504 Phase 3
12 Combination Chemotherapy in Treating Patients With Bladder Cancer Completed NCT00003701 Phase 3 carboplatin;cisplatin;doxorubicin hydrochloride;methotrexate;paclitaxel;vinblastine sulfate
13 Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium Completed NCT00003376 Phase 3 carboplatin;cisplatin;doxorubicin hydrochloride;methotrexate;paclitaxel;vinblastine
14 Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer Completed NCT00022191 Phase 3 cisplatin;gemcitabine hydrochloride;paclitaxel
15 Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium Completed NCT00014274 Phase 2, Phase 3 carboplatin;gemcitabine hydrochloride;methotrexate;vinblastine sulfate
16 Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma Recruiting NCT03296306 Phase 3 Treatment duration of cisplatin based chemotherapy
17 Liposomal Bupivacaine To Control Post-Operative Pain Following BMG Active, not recruiting NCT03720223 Phase 3 Liposomal Bupivacaine
18 Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Active, not recruiting NCT00942331 Phase 3 Cisplatin;Gemcitabine Hydrochloride
19 Effectiveness and Safety of Autologous Adipose-Derived Regenerative Cells for the Treatment of Urethral Strictures Unknown status NCT01889888 Phase 1, Phase 2
20 Effect of Mitomycin C on Urethral Stricture Recurrence After Internal Urethrotomy Unknown status NCT00918528 Phase 1, Phase 2 Mitomycin C - local injection
21 Effectiveness and Safety of Adipose-derived Regenerative Cells for Reduction of Risk of Bladder Neck Contracture Unknown status NCT02869061 Phase 1, Phase 2
22 A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer Unknown status NCT01326871 Phase 1, Phase 2 Cisplatin;Gemcitabine
23 Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer Unknown status NCT01191892 Phase 2 carboplatin;gemcitabine hydrochloride;vandetanib;Placebo
24 Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer Unknown status NCT01118039 Phase 2 sunitinib malate
25 Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract Unknown status NCT00006111 Phase 2 cisplatin;fluorouracil
26 NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole) Completed NCT00322465 Phase 2 Tinidazole;Doxycycline;Azithromycin
27 Role of Uttarbasti in the Management of Mutra Marga Sankoch (Urethral Stricture) Completed NCT00535717 Phase 2
28 Study to Improve Partner Services for STD Prevention Completed NCT00207467 Phase 2
29 Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction Completed NCT00507455 Phase 2 solifenacin succinate;tamsulosin hydrochloride;Placebo to solifenacin;Placebo to tamsulosin
30 A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO) Completed NCT00410514 Phase 2 Mirabegron;Placebo
31 Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium Completed NCT01090466 Phase 1, Phase 2 cisplatin;gemcitabine hydrochloride;temsirolimus
32 Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT) Completed NCT01089088 Phase 2 cisplatin;gemcitabine hydrochloride;sunitinib malate
33 Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to Treatment Completed NCT01031875 Phase 2 pazopanib hydrochloride
34 A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer Completed NCT00661609 Phase 2 AZD4877
35 Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function Completed NCT00478361 Phase 2 Gemcitabine hydrochloride;Paclitaxel;Doxorubicin hydrochloride;Pegfilgrastim
36 Pazopanib in Treating Patients With Metastatic Urothelial Cancer Completed NCT00471536 Phase 2 pazopanib hydrochloride
37 VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium Completed NCT00407485 Phase 2
38 Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium Completed NCT00397488 Phase 2 sunitinib malate
39 Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma Completed NCT00252941 Phase 1, Phase 2
40 Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract Completed NCT00002914 Phase 2 piritrexim
41 Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer Completed NCT00003175 Phase 2 fluorouracil
42 Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium Completed NCT00080795 Phase 2 cisplatin;doxorubicin hydrochloride;gemcitabine hydrochloride;ifosfamide
43 Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract Completed NCT00006026 Phase 2 rubitecan
44 Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer Completed NCT00004223 Phase 2 docetaxel;gemcitabine hydrochloride
45 TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium Completed NCT00077688 Phase 2 TOCOSOL Paclitaxel
46 Arsenic Trioxide in Treating Patients With Urothelial Cancer Completed NCT00009867 Phase 2 arsenic trioxide
47 Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma Completed NCT00072150 Phase 2 bortezomib
48 S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract Completed NCT00014144 Phase 2 gefitinib
49 Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer Completed NCT00021099 Phase 2 ixabepilone
50 S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy Completed NCT00066612 Phase 2 irinotecan hydrochloride

Search NIH Clinical Center for Urethral Syndrome

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: urethral diseases

Genetic Tests for Urethral Syndrome

Genetic tests related to Urethral Syndrome:

# Genetic test Affiliating Genes
1 Abnormality of the Urethra 30

Anatomical Context for Urethral Syndrome

MalaCards organs/tissues related to Urethral Syndrome:

42
Testes, Prostate, Kidney, Endothelial, Cervix

The Foundational Model of Anatomy Ontology organs/tissues related to Urethral Syndrome:

20
The Urethra

Publications for Urethral Syndrome

Articles related to Urethral Syndrome:

(show top 50) (show all 138)
# Title Authors Year
1
A prospective study to evaluate the efficacy of cistiquer in improving lower urinary tract symptoms in females with urethral syndrome. ( 25034330 )
2014
2
The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain. ( 21176078 )
2011
3
Treatment of urethral syndrome: a prospective randomized study with Nd:YAG laser. ( 16493214 )
2006
4
Urethral syndrome: response to alpha-adrenergic blocking agents. ( 16261427 )
2006
5
Treatment of post-menopausal urethral syndrome with the formula niao chang shu--a report of 40 cases. ( 15119161 )
2004
6
Dr. Li Yueqing's experience in treating female urethral syndrome. ( 15270256 )
2004
7
Imaging of urethral disease: a pictorial review. ( 15486241 )
2004
8
Electric acupuncture in the treatment of 36 cases of female urethral syndrome. ( 14719301 )
2003
9
Transabdominal vesical sonography of urethral syndrome and stress incontinence. ( 12534925 )
2003
10
Prostatitis, interstitial cystitis, chronic pelvic pain, and urethral syndrome share a common pathophysiology: lower urinary dysfunctional epithelium and potassium recycling. ( 14665339 )
2003
11
Treatment of female urethral syndrome refractory to antibiotics. ( 12402379 )
2002
12
A technique of bladder neck closure combining prostatectomy and intestinal interposition for unsalvageable urethral disease. ( 11792934 )
2002
13
The incidence of Chlamydia trachomatis in women with urethral syndrome. ( 11695072 )
2001
14
Azithromycin and doxycycline in the treatment of female patients with acute urethral syndrome caused by Ureaplasma urealyticum: significance of duration of clinical symptoms. ( 11822223 )
2001
15
Intravesical potassium sensitivity in patients with interstitial cystitis and urethral syndrome. ( 11248610 )
2001
16
Duration of clinical symptoms in female patients with acute urethral syndrome caused by Chlamydia trachomatis treated with azithromycin or doxycycline. ( 11330365 )
2001
17
Comparative analysis of azithromycin and doxycycline efficacy in the treatment of female patients with acute urethral syndrome caused by Ureaplasma urealyticum. ( 10789560 )
2000
18
Duration of clinical symptoms in female patients with acute urethral syndrome caused by Ureaplasma urealyticum treated with azithromycin or doxycycline. ( 11154040 )
2000
19
Radiological evaluation of urethral disease ( 10828679 )
2000
20
Urethral syndrome and associated risk factors related to obstetrics and gynecology. ( 10221602 )
1999
21
Equal symptomatic outcome after antibacterial treatment of acute lower urinary tract infection and the acute urethral syndrome in adult women. ( 10555247 )
1999
22
Urinary bacterial flora of women with urethral syndrome and interstitial cystitis. ( 9852391 )
1999
23
Study on acupuncture and moxibustion therapy for female urethral syndrome. ( 10437230 )
1998
24
Female urethral syndrome. A female prostatitis? ( 8686301 )
1996
25
The urethral syndrome: a controlled evaluation. J Psychosom Res 1993; 37: 737-743. ( 8027965 )
1994
26
Urethral syndrome: clinical results with antibiotics alone or combined with estrogen. ( 7957464 )
1994
27
The urethral syndrome and its management. ( 7928838 )
1994
28
Fibromyalgia associated with female urethral syndrome. ( 8187451 )
1994
29
The urethral syndrome: a controlled evaluation. ( 8229904 )
1993
30
Surgical repair of hypospadias in women with symptoms of urethral syndrome. ( 1569664 )
1992
31
The urethral syndrome--why what we do works, or doesn't. ( 1479977 )
1992
32
A psychophysiological evaluation of female urethral syndrome: evidence for a muscular abnormality. ( 1625341 )
1992
33
The mysterious "urethral syndrome". ( 1859947 )
1991
34
The mysterious "urethral syndrome". ( 1912784 )
1991
35
Infiltrative urethral disease in female dogs: 41 cases (1980-1987). ( 1890037 )
1991
36
The painful bladder: urethral syndrome and interstitial cystitis. ( 2130959 )
1990
37
Prostatodynia or painful male urethral syndrome? ( 2385883 )
1990
38
The urethral syndrome: myth or reality? A commentary. ( 2233643 )
1990
39
Genitourinary manifestations of fibrositis: an increased association with the female urethral syndrome. ( 2319522 )
1990
40
Interstitial cystitis and the urethral syndrome: a possible answer. ( 2670041 )
1989
41
Urethral syndrome. A comparison of different treatment modalities. ( 2926732 )
1989
42
Urethral syndrome: a study in psychosomatic urology. ( 2486388 )
1989
43
Cryosurgery versus dilation and massage for the treatment of recurrent urethral syndrome. ( 2810238 )
1989
44
Pharmacokinetic data and therapeutic efficacy of miocamycin: serum, urinary and prostatic levels. Therapeutic aspects in acute urethral syndrome and non-gonococcal urethritis. ( 16312542 )
1989
45
The urethral syndrome. ( 3055620 )
1988
46
Sexually transmitted diseases in women with urethral syndrome. ( 2903082 )
1988
47
The urethral syndrome. ( 3170107 )
1988
48
Efficacy of miocamycin in the therapy of non-specific genital infections (NSGI): non-gonococcal urethritis (NGU) and acute urethral syndrome (AUS). ( 3259948 )
1988
49
Urethral syndrome: patient suggestions. ( 3420419 )
1988
50
The acute urethral syndrome in routine practice. ( 3494789 )
1987

Variations for Urethral Syndrome

Expression for Urethral Syndrome

Search GEO for disease gene expression data for Urethral Syndrome.

Pathways for Urethral Syndrome

GO Terms for Urethral Syndrome

Sources for Urethral Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....